Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Open Access
- 14 October 2010
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (3) , 434-438
- https://doi.org/10.1016/j.bbmt.2010.10.002
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA142106)
- Jock and Bunny Adams Education and Research Fund
This publication has 22 references indexed in Scilit:
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Influenza vaccination in hematopoietic SCT recipientsBone Marrow Transplantation, 2008
- Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell TransplantationTransplantation, 2008
- The benefit of influenza vaccination after bone marrow transplantationBone Marrow Transplantation, 2005
- Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised studyBritish Journal of Haematology, 2005
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004
- Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2001
- Granulocyte-Macrophage Colony-Stimulating Factor as Immunomodulating Factor Together with Influenza Vaccination in Stem Cell Transplant PatientsClinical Infectious Diseases, 2000
- Respiratory Virus Infections in Bone Marrow Transplant Recipients: The European PerspectiveThe American Journal of Medicine, 1997